POSIFIT S.A.S. is a private company created in 2007. It is one of the founder members of Nancyclotep EIG.
POSIFIT S.A.S is the industrial development operator of NANCYCLOTEP and have a privileged access to university and hospital resources.
In early 2021, POSIFIT became a pharmaceutical company and obtained the GMP certificate for radiopharmaceuticals production destined for use in clinical trials in the Starsbourg location
Our objective is to become an essential link, in France and in Europe, in imaging and therapy radiopharmaceuticals production.
We provide expertise and infrastructures to the various players, for the radiopharmaceutical development, production as well, monitoring of clinical trials.